Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Stephen A. Sherwin
Age : 73
Public asset : 6,023,757 USD
Linked companies : Biogen Inc. - Neurocrine Biosciences, Inc. - BioPlus Acquisition Corp.
Summary 
Dr. Stephen A. Sherwin, MD, is a Venture Partner at Third Rock Ventures LLC, an Independent Director at Biogen, Inc., an Independent Director at Neurocrine Biosciences, Inc., a Clinical Professor at The University of California, San Francisco, an Independent Director at BioPlus Acquisition Corp., a Member at American Association for Cancer Research, a Member at American Society of Clinical Oncology and a Professor at University of California.

He is on the Board of Directors at Biogen, Inc., Biogen GmbH, Neurocrine Biosciences, Inc., Rheos Medicines, Inc. and BioPlus Acquisition Corp. Dr. Sherwin was previously employed as an Independent Director by Neon Therapeutics, Inc., an Independent Director by Aduro BioTech, Inc., an Independent Director by Vical, Inc., an Independent Director by Verastem, Inc., a Chairman-Emeritus by Biotechnology Industry Organization, a Chairman by Ceregene, Inc., an Independent Director by Rigel Pharmaceuticals, Inc., a Chairman & Chief Executive Officer by Cell Genesys, Inc., a Vice President-Clinical Research by Genentech, Inc., a Chairman by Abgenix, Inc., and a Principal by National Cancer Institute.

He also served on the board at BioSante Pharmaceuticals, Inc. and Biogen Idec New Ventures, Inc.

He received his undergraduate degree from Yale University and a doctorate degree from Harvard Medical School.


Current positions of Stephen A. Sherwin 
NameTitle Since
Biogen Inc.
(Pharmaceuticals)
Independent Director 2010
Neurocrine Biosciences, Inc.
(Biotechnology & Medical Research)
Independent Director 1999
BioPlus Acquisition Corp.
(Investment Holding Companies)
Independent Director -
Biogen GmbH Member-Supervisory Board 2010
Rheos Medicines, Inc. Director -
The University of California, San Francisco Professor -
American Society of Clinical Oncology Member -
American Association for Cancer Research Member -
University of California Professor -
Third Rock Ventures LLC Venture Partner 2016


Holdings of Stephen A. Sherwin 
NameEquities%Valuation
Biogen Inc. (BIIB)
(Pharmaceuticals)
16,2130.011%3,889,823 USD
Neurocrine Biosciences, Inc. (NBIX)
(Biotechnology & Medical Research)
25,0550.026%2,133,934 USD


Stephen A. Sherwin: Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
RE
01/11JAMIE DIMON : JPMorgan's Dimon says consumer loan growth may take 6-9 months to return to normal
RE
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
RE
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
RE
01/20ALAN JOPE : Unilever strategy under scrutiny after short-lived GSK skirmish
RE
01/24ELON MUSK : Tesla countersues JPMorgan, claims bank sought 'windfall' after Musk tweet
RE
01/11CATHIE WOOD : ARK's Wood turns focus to deflation, 'stay connected' stocks
RE
01/23NELSON PELTZ : Nelson Peltz's Trian builds stake in Unilever - source
RE
01/12MARTIN SORRELL : Sorrell's S4 says trading well ahead of guidance
RE
01/13AMANCIO ORTEGA : Inditex founder Amancio Ortega buys Toronto's Royal Bank Plaza for $916 mln
RE
More news


© 2022 People and Ownership :   
Stephen A. Sherwin : Connections